肺癌
免疫疗法
雌激素受体
医学
雌激素
肿瘤科
癌症
免疫系统
内科学
肺
癌症研究
乳腺癌
免疫学
作者
Karmele Valencia,Luis M. Montuenga,Alfonso Calvo
标识
DOI:10.1158/1078-0432.ccr-23-1736
摘要
Summary The influence of sex on immunotherapy response in patients with non–small cell lung cancer (NSCLC) had been studied with no clear conclusions. An article in this issue reports that a key determinant of response is not sex but the existence of a 17β-estradiol/ERα/PDL1 signaling loop in NSCLC. This intriguing result opens new therapeutic options. See related article by Anobile et al., p. 3958
科研通智能强力驱动
Strongly Powered by AbleSci AI